Merckle GmbH, PLIVA Croatia Ltd., Teva Operations Poland Sp. z o.o.

Poland

All drugs from this manufacturer

  • LENALIDOMIDE TEVA

    The medicinal product is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 5 mg

    ATC: L04AX04

  • LENALIDOMIDE TEVA

    The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 10 mg

    ATC: L04AX04

  • LENALIDOMIDE TEVA

    The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 15 mg

    ATC: L04AX04